HMGB1 promotes myeloid-derived suppressor cells and renal cell carcinoma immune escape
Jinfeng Li(Beijing Institute of Technology), Feifei Luo(Jiangxi University of Traditional Chinese Medicine), Jiajia Sun(First Affiliated Hospital of Zhengzhou University), Guiwen Feng(First Affiliated Hospital of Zhengzhou University), Ruiming Rong(Shandong University of Traditional Chinese Medicine), Li Long(Sun Yat-sen University), Dongkui Song(UNSW Sydney), Wenjun Shang(First Affiliated Hospital of Zhengzhou University)
Cited by 42
Related Papers
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia
|Cancer Immunology Research|2018|137
TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
|The Journal of Immunology|2011|132